• P A K Trindade, F P M Giglio, B L Colombini-Ishikiriama, A M Calvo, K C S Modena, D A Ribeiro, T J Dionísio, D T Brozoski, J R P Lauris, F A C Faria, and C F Santos.
• Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.
• Int J Oral Maxillofac Surg. 2011 Mar 1; 40 (3): 292-7.

AbstractIn this study, 53 patients received piroxicam, administered orally or sublingually, after undergoing removal of symmetrically positioned lower third molars, during two separate appointments. This study used a randomized, blind, cross-over protocol. Objective and subjective parameters were recorded for comparison of postoperative results for 7 days after surgery. Patients treated with oral or sublingual piroxicam reported low postoperative pain scores. The patients who received piroxicam orally took a similar average amount of analgesic rescue medication compared with patients who received piroxicam sublingually (p>0.05). Patients exhibited similar values for mouth opening measured just before surgery and immediately following suture removal 7 days later (p>0.05), and showed no significant differences between routes of piroxicam administration for swelling control during the second or seventh postoperative days (p>0.05). In summary, pain, trismus and swelling after lower third molar extraction, independent of surgical difficulty, could be controlled by piroxicam 20mg administered orally or sublingually and no significant differences were observed between the route of delivery used in this study.Copyright © 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

43 keywords...

hide…